GSGaurav Kant Saraogi

Gaurav Kant Saraogi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gaurav Kant Saraogi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Glycosylation in Cancer Medicines Delivery and Their Patents

    by Biswa Mohan Sahoo, Shikha Sharma, Payal Bhatnagar, Gaurav Kant Saraogi, Bimal Krishna Banik

    Glycosylation plays a significant part in cancer pathophysiology, shaping tumour progression, metastasis, immune evasion, and drug resistance. Aberrant glycosylation patterns in tumours serve as impending biomarkers and therapeutic targets for enriched cancer diagnostics and treatment strategies. Developments in glycosylation-mediated drug delivery systems (DDSs) have enabled more targeted targeting of tumour cells through receptor-specific interactions, boosting drug efficacy while mitigating systemic toxicity. Glycosylated nanocarriers, antibodies, and fusion proteins have proven favourable applications in anticancer therapies, improving drug stability, cellular uptake, and immune modulation. Recent patents focus on innovative advances leveraging glycosylation to improve drug targeting, stability, and therapeutic efficacy, predominantly in addressing multidrug resistance in cancers such as non-small cell lung cancer, breast cancer, and prostate cancer. Narrative review, synthesizing published research and patents related to glycosylation-mediated drug delivery for cancer. Peer-reviewed journal articles and patents retrieved from European, Google Patents, and Lens.org databases (2020–2025) using keywords such as cancer, glycosylation, drug, medicine, oncology. Covers glycosylation biology in cancer, receptor-mediated targeting, applications in nanocarriers and antibodies, roles in metastasis, immune evasion, metabolism, ferroptosis, senescence, biomarkers, and delivery systems. Qualitative synthesis of literature findings and patent specifications, categorizing them by therapeutic approach, target, stage of development, and potential for clinical translation. Identification of trends, challenges, and future perspectives in glycosylation-based drug delivery. This review surveys the structural and functional aspects of glycosylation in cancer biology, its effects on tumour behaviour, and its emerging role in personalised medicine through glycosylation-based diagnostics and targeted therapeutics.

  • Exploring the Molecular Pathways of Tinospora cordifolia in the Management of Diabetic Foot Ulcers

    by Mamta Kumari, Piyushkumar Sadhu, Niyati Shah, Chitrali Talele, Gaurav Kant Saraogi, Shikha Sharma

    Introduction: Medicinal plants are increasingly recognized as alternative and complementary therapies, particularly in India and other Asian countries. Tinospora cordifolia (Giloy/Guduchi) is a well-known medicinal plant with extensive therapeutic applications, including immune modulation, antidiabetic, anti-inflammatory, antioxidant, and antimicrobial effects. Given these properties, T. cordifolia shows promise for managing Diabetic Foot Ulcers (DFUs), a severe complication of diabetes associated with infection and the risk of amputation. Methods: This review compiles and critically analyzes the published literature on T. cordifolia, focusing on its phytochemical composition, pharmacological activities, and therapeutic relevance to diabetic foot ulcers. Data were gathered from PubMed, Scopus, Web of Science, and Google Scholar, including experimental, preclinical, and clinical studies describing its bioactive constituents and mechanisms related to immune regulation and wound healing Results: Bioactive compounds such as alkaloids, diterpenoids, and polysaccharides derived from the stem, root, and whole plant exhibit significant immunomodulatory, anti-inflammatory, antioxidant, and antibacterial activities. These properties collectively support enhanced wound healing, infection control, and immune regulation, indicating the potential effectiveness of T. cordifolia in the treatment of DFU. Its favorable physiological compatibility and minimal side effects further strengthen its therapeutic value. Discussion: The multifaceted pharmacological actions of T. cordifolia align well with the complex pathophysiology of diabetic foot ulcers, which involves impaired immunity, chronic inflammation, oxidative stress, and microbial infection. The plant’s immune-modulating and wound-healing effects suggest its usefulness as an adjunct to conventional DFU therapies. However, mechanistic insights and standardized clinical evidence remain limited. Conclusion: Tinospora cordifolia represents a promising adjunctive therapeutic option for the management of diabetic foot ulcers. Future research should emphasize detailed biochemical mechanisms, synergistic effects with conventional drugs or other herbs, and well-designed clinical trials. Its incorporation into nutraceuticals and dietary supplements may further aid in chronic disease management and immune enhancement, bridging traditional knowledge with modern therapeutic strategies.

  • Integration of Nanotechnology with Hydrogel: A Promising Strategy for Cancer Therapy

    by Gaurav Kant Saraogi, Gurpreet Singh, Pratibha Bhide, Shikha Sharma, Bimal Krishna Banik

    Introduction: Hydrogels are highly versatile materials in biomedical and pharmaceutical applications due to their excellent biocompatibility, tenable properties, and ability to mimic the natural extracellular matrix. These three-dimensional polymeric networks exhibit outstanding waterretention capacity, making them ideal for use in tissue engineering, wound healing, and controlled drug delivery systems. Recent advances in hydrogel technology have led to the development of "smart" hydrogels that respond to external stimuli such as pH, temperature, and specific biomolecular interactions, significantly enhancing their potential for targeted therapies. Functionalization with bioactive molecules and integration with nanotechnology have further broadened their scope, enabling applications in regenerative medicine and precision healthcare. Despite these promising developments, challenges remain—particularly concerning large-scale production, mechanical strength, and controlled degradation kinetics. Methods: To obtain the necessary data, the procedure involves thoroughly searching multiple databases, including PubMed, ScienceDirect, and SciFinder, for citations relevant to the topic under investigation. Results: This study provides a comprehensive overview of hydrogel classification, synthesis methods, physicochemical properties, and biological applications. It also explores innovative strategies to overcome existing limitations. The integration of hydrogels with cutting-edge technologies such as 3D bioprinting, nanomedicine, and artificial intelligence underscores their growing significance in translational medicine. Conclusion: By combining the aforementioned advantages, hydrogel materials have emerged as a breakthrough in cancer treatment, offering promising potential to enhance both the survival rate and quality of life for cancer patients.

  • Immunomodulatory Roles of Probiotics: From Intestinal Barrier Regulation to Clinical Applications

    by Gaurav Kant Sarogi, Anurag Agrawal, Mamta Kumari, Shikha Sharma, Aakash Sharma, Mukesh Kumar Gupta, Bimal Krishna Banik

    The mammalian gut is a highly dynamic physiological ecosystem that harbors an enormous number of commensal bacteria that play an essential role in the development of various cells of the immune system. The gut bacteria, both resident and diet-derived, share a habitat with immune cells located within the lamina propria layer of the intestinal villi. The intestinal epithelial cells do not come into direct contact with the gut microbiota, but microbial metabolites play a significant role in their maturation and appropriate function. According to the World Health Organization, probiotics are "live microorganisms which, when administered in adequate amounts, confer a health benefit on the host." The microbiota found within the human gut has been evolutionarily selected based on their suitability to survive within the GT. Lactic acid bacteria, belonging to Pediococcus, Lactobacilli, Streptococci, Bifidobacteria, Enterococcus, and yeast cells like Saccharomyces boulardii, are found to be predominantly used as a source of probiotics. However, these properties are strain-specific and not a general feature of all bacteria. To maintain immunological homeostasis and control both the innate and adaptive immune responses, immune cells, nutrients, and commensal microbes continuously interact in dynamic processes in a stable environment. This interaction allows the host to enhance immunity through improved immunological responses to diseases, including inflammatory and infectious conditions. Among specific benefits are infection prevention, alleviation of symptoms associated with Helicobacter pylori suppression, irritable bowel syndrome management, cancer prevention, reduction of gut inflammation, and allergy, diabetes, and drug-resistant pathogen prevention. This review focuses on compiling key findings up to date and discussing their implications in the interaction between probiotics and immune cells towards immune function.


  • Dietary Interventions in ROS-Mediated Metabolic Disorders

    by Prachi Jagdev, Jaipreet Singh, Sarita Sharma, Sumeet Gupta, Gaurav Kant Saraogi, Raghavendra Pai

  • Open Access

    Comparative in vitro evaluation of glimepiride containing nanosuspension drug delivery system developed by different techniques

    by Sujit Bose, Pooja Sharma, Vijay Mishra, Swati Patial, Gaurav K. Saraogi, Murtaza M. Tambuwala, Kamal Dua